Jonathan Miller
Stock Analyst at Evercore ISI Group
(n/a)
# 4,408
Out of 4,415 analysts
5
Total ratings
n/a
Success rate
-46.95%
Average return
Main Sectors:
Top Industries:
5 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PROK ProKidney | Initiates: Outperform | n/a | $2.15 | - | 1 | Sep 2, 2022 | |
| VAXX Vaxxinity | Initiates: In-Line | n/a | $0.10 | - | 1 | Apr 27, 2022 | |
| TRDA Entrada Therapeutics | Initiates: Outperform | n/a | $13.56 | - | 1 | Nov 24, 2021 | |
| STTK Shattuck Labs | Initiates: Outperform | n/a | $11.10 | - | 1 | Jan 11, 2021 | |
| NBTX Nanobiotix | Initiates: Outperform | n/a | $6.05 | - | 1 | Jan 6, 2021 |
ProKidney
Sep 2, 2022
Initiates: Outperform
Price Target: n/a
Current: $2.15
Upside: -
Vaxxinity
Apr 27, 2022
Initiates: In-Line
Price Target: n/a
Current: $0.10
Upside: -
Entrada Therapeutics
Nov 24, 2021
Initiates: Outperform
Price Target: n/a
Current: $13.56
Upside: -
Shattuck Labs
Jan 11, 2021
Initiates: Outperform
Price Target: n/a
Current: $11.10
Upside: -
Nanobiotix
Jan 6, 2021
Initiates: Outperform
Price Target: n/a
Current: $6.05
Upside: -